Mirum Pharmaceuticals Inc (MIRM) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $92.19
• Market Cap: $6.50B
• EPS: $-0.84
• 52-Week High: $109.28
• 52-Week Low: $36.88

Market Sentiment

Mirum Pharmaceuticals Inc currently has a Bullish sentiment score of 0.26.

About Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals, Inc., headquartered in Foster City, California, is a biopharmaceutical company dedicated to developing innovative therapies for severe liver diseases. The company boasts a strong pipeline, featuring novel treatment candidates that target significant unmet medical needs in hepatology. With a clear focus on clinical development and a commitment to patient-centered care, Mirum presents a compelling opportunity for institutional investors seeking exposure to transformative ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Mirum Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MIRM pay dividends?

Mirum Pharmaceuticals Inc (MIRM) does not currently pay a regular dividend.

What is MIRM's market cap?

Mirum Pharmaceuticals Inc (MIRM) has a market capitalization of $6.50B with a current stock price of $92.19.